1-(arylmethyl)quinazoline-2,4(1H,3H)-diones as PARP inhibitors and the use thereof

PARA-SUBSTITUTED INDANYL AND TETRALINYL DERIVATIVES

Inhibitors of ACK1/TNK2 tyrosine kinase

Bisamidinium-based inhibitors for the treatment of myotonic dystrophy

Method for preparing methyl (Z)-3-[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenyl]amino]phenylmethylene)oxindole-6-carboxylate (intedanib, nintedanib)

PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS

Polymorphs of Selinexor

SIK INHIBITOR FOR USE IN A METHOD OF TREATING AN INFLAMMATORY AND/OR IMMUNE DISORDER

Organic electroluminescent device, thin luminous film, display apparatus, and lighting apparatus

Substituted oxazoles for the treatment of cancer

Compounds, compositions, and methods

DNA-PK inhibitors

Indanylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors

Pyrimidine derivatives for the treatment of viral infections

SUBSTITUTED CYCLIC ARYL AND HETEROARYL CARBOXYLIC ACID HYDRAZIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS

TRIAZOLE COMPOUND

Method of inhibiting DYRK1B

Phenoxymethyl derivatives

P2X4 receptor antagonist

S1P3 ANTAGONISTS

Method and apparatus for sorting heterogeneous material

Triazolone compounds as MPGES-1 inhibitors

Nitrogen-containing compounds suitable for use in the production of polyurethanes

Bicyclic heterocyclic amide derivative

HETERO-HALO INHIBITORS OF HISTONE DEACETYLASE

Pyrimidines as EGFR inhibitors and methods of treating disorders

NEPRILYSIN INHIBITORS

Compounds for the treatment of HIV

Methods to treat lymphoplasmacytic lymphoma

Hydantoin containing deoxyuridine triphosphatase inhibitors

DNA-PK inhibitors

NEPRILYSIN INHIBITORS

SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE

N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide derivatives with herbicidal action

Inhibitors of protein kinases

NOVEL ANNELATED BENZAMIDES

Antibacterial compounds

Substituted benzotriazole phenols

LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF

Spiro[cyclobutane-1,3′-indolin]-2′-one derivatives as bromodomain inhibitors

Hydantoin containing deoxyuridine triphosphatase inhibitors

Modulators of cystic fibrosis transmembrane conductance regulator

Phthalazinone derivatives

Inhibitors of the TEC Kinase Enzyme Family

Inhibitors of lysine specific demethylase-1

Metallo-β-lactamase inhibitors

Substituted piperazine compounds and methods of use and use thereof

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

Amino compounds for treatment of immune and inflammatory disorders

Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds

SMALL MOLECULE INHIBITORS OF GP120-MEDIATED HIV INFECTION AND METHODS OF USE

Efflux-pump inhibitors and therapeutic uses thereof

Therapeutic compositions, combinations, and methods of use

Herbicidal compounds

Composition for electrode protective film of electrostatic capacitance-type input device, electrode protective film of electrostatic capacitance-type input device, transfer film, laminate, electrostatic capacitance-type input device, and image display device

Pyrimidine-2,4-diamine derivatives for treatment of cancer

Substituted pyrazines as ATR kinase inhibitors

MALEATE SALTS OF A QUINAZOLINE DERIVATIVE USEFUL AS AN ANTIANGIOGENIC AGENT

Salicylate inhibitors of MELK and methods of use

Pyrrolcarboxamide derivatives for the inhibition of ERK5

Benzimidazole compound and medical use thereof

Pyrazole derivative or pharmaceutically acceptable salt thereof

Histone deacetylase inhibitors

HYDROXYLATED AND METHOXYLATED PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

ORGANIC LIGHT-EMITTING DEVICE AND COMPOUND

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

Compounds

Modulators of ATP-binding cassette transporters

Non-selective kinase inhibitors

Phthalazinones and isoquinolinones as rock inhibitors

Covalent inhibitors of kras G12C

Pendant amines and derivatives as inhibitors of leukotriene A4 hydrolase

DNA-PK inhibitors

Pyrimidine derivatives as kinase inhibitors and their therapeutical applications

Substituted pyrimidines containing acidic groups as TLR7 modulators

SPIROCYCLOHEPTANES AS INHIBITORS OF ROCK

CXCR4 chemokine receptor modulators

Substituted Heterocyclyl Derivatives as CDK Inhibitors

Cytotoxic peptides and conjugates thereof

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

N-phenyl-carboxamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

Method of treating Crohn's disease comprising a TLR2 antagonist

Pyrazolyl-substituted heteroaryls and their use as medicaments

SUBSTITUTED QUINOXALINE DERIVATIVES

Heterocyclic compounds as inhibitors of Vanin-1 enzyme

Substituted guanidines as fungicides

Substituted pyrazole compounds containing pyrimidine and preparation method and use thereof

Diamide macrocycles as factor XIa inhibitors

DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS

Process for preparing 4-amino-pyridazines

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

INDOLE AND AZAINDOLE DERIVATIVE HAVING AMPK-ACTIVATING ACTIVITY

Sulphamoylpyrrolamide derivatives and the use thereof as medicaments for the treatment of hepatitis B

Site-specific covalent chemical ligation to monoclonal and polyclonal immunoglobulin

Indazoles and use thereof

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-I-yl) ureas as P38 mapkinase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE

Oxindole compounds and pharmaceutical compositions thereof

Bicyclic-fused heteroaryl or aryl compounds

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

Hydrazide containing nuclear transport modulators and uses thereof

Tetrasubstituted alkene compounds and their use

Pro-Neurogenic Compounds

Substituted quinazolines for inhibiting kinase activity

PREPARATION AND METHODS OF USE FOR ORTHO-ARYL 5-MEMBERED HETEROARYL-CARBOXAMIDE CONTAINING MULTI-TARGETED KINASE INHIBITORS

Bicyclic derivatives

Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof

Triazole benzamide derivatives and the compositions and methods of treatment regarding the same

Neprilysin inhibitors

6-membered heterocyclic derivatives and pharmaceutical composition comprising the same

Heterocyclic derivatives modulating activity of certain protein kinases

Indolone compounds and their use as AMPA receptor modulators

SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS

Herbicidal compounds

FYN kinase inhibitors

Amide compounds and method for making and using

N2-(2-methoxyphenyl)pyrimidine derivative, method for preparing same, and pharmaceutical composition for cancer prevention or treatment containing same as active ingredient

N-alkylaryl-5-oxyaryl-octahydro-cyclopenta[c]pyrrole negative allosteric modulators of NR2B

Herbicidal compounds

TrkA kinase inhibitors, compositions and methods thereof

Pyrazole compounds or salts thereof, preparation methods therefor, herbicidal compositions and use thereof

Substituted benzimidazolium compounds useful in the treatment of respiratory diseases

Amino-substituted heterocyclic derivatives as sodium channel inhibitors

Therapeutic compounds and methods of use thereof

ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF

Pyrazole compounds and their use as T-type calcium channel blockers

Radiotracer derivatives of trimethoprim for diagnostic imaging

Therapeutic compounds and uses thereof

Compounds for the prevention and treatment of cardiovascular diseases

Tricyclic Amino Containing Compounds for Treatment or Prevention of Symptoms Associated with Endocrine Dysfunction

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

Compounds, compositions and methods

Inhibitors of histone deacetylase

Hepatitis B viral assembly effectors

Process for the preparation of androgen receptor antagonists and intermediates thereof

NOVEL ARYL-CYANOGUANIDINE COMPOUNDS

Substituted pyrrolidines and methods of use

Heteroaryl amides as inhibitors of protein aggregation

Biaryl inhibitors of bruton's tyrosine kinase

Crystalline FGFR4 inhibitor compound and uses thereof

Quinazolinones as bromodomain inhibitors

Somatostatin receptor subtype 4 (SSTR4) agonists

Kinase inhibitors

BIOCIDAL COATINGS AND METHODS FOR MAKING SAME

PLK4 inhibitors

Pyrazole compounds or salts thereof, preparation method therefor, herbicidal composition and use thereof

Therapeutic compounds and uses thereof

Substituted indazoles for treating tendon and/or ligament injuries

PROCESS FOR PREPARING PYRAZOLES

CGAS in systemic lupus erythematosus (SLE)

1-cyano-pyrrolidine compounds as USP30 inhibitors

DRUG-CONJUGATES, CONJUGATION METHODS, AND USES THEREOF

Modulators of toll-like receptors

Salts of quinazoline derivative and method for preparing the same

Methods for treating cancer with RORγ inhibitors

Stable yellow imidazolium compounds

Process for producing purinone derivative

ANTI-PCSK9 COMPOUNDS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES

9-membered fused ring derivative

Substituted 6,7-dihydro-5H-benzo[7]annulene compounds, processes for their preparation and therapeutic uses thereof

METHODS FOR TREATING CANCER WITH TRKA RECEPTOR TYROSINE KINASE ANTAGONISTS

STABLE VIOLET-BLUE TO BLUE IMIDAZOLIUM COMPOUNDS

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

HETEROARYL SYK INHIBITORS

INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS

PHARMACOKINETICALLY IMPROVED COMPOUNDS

Sodium channel modulators

Carbazole-containing sulfonamides as cryptochrome modulators

Fumarate analogs and uses thereof

SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE

Diazole amides

Compositions and methods for treating respiratory injury or disease

Spiroquinoxaline derivatives as inhibitors of non-apoptotic regulated cell-death

Process for making beta 3 agonists and intermediates

PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS

HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS

Synthetic route to anti-viral agents

Solid forms of cenicriviroc mesylate and processes of making solid forms of cenicriviroc mesylate

Inhibitors of Necroptosis

Compounds useful as immunomodulators

Pyridazine derivatives as RORc modulators

Compounds, compositions, and methods

Substituted tetrazolinones for controlling plant diseases

Direct AMPK activators

NOVEL FLUORINATED DERIVATIVES AS EGFR INHIBITORS USEFUL FOR TREATING CANCERS

Neprilysin inhibitors

Substituted cyclic amides as herbicides

Heterocyclic compounds and uses thereof

Histone demethylase inhibitors

Pyrazolyl derivatives as pest control agents

Urea derivative or pharmacologically acceptable salt thereof

Kinase inhibitors

Sulfonylureas and related compounds and use of same

Theramutein modulators

Heteroaromatic compounds and their use as dopamine D1 ligands

Therapeutic compounds and uses thereof

Aminoquinazoline compounds as Aantagonist

Ethylenediaminetetraacetic acid bis(amide) derivatives and their respective complexes with Mn(II) ion for use as MRI contrast agent

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

Factor IXa inhibitors

Quinazolines as potassium ion channel inhibitors

INHIBITORS OF BRUTON'S TYROSINE KINASE

Bicyclic quinazolinone derivatives

Pyridazinone and pyridone compounds

Pharmaceutically active compounds

Inhibitor of lysine specific demethylase-1

Compounds for treatment of complement mediated disorders

Ether compounds for treatment of complement mediated disorders

Compounds, compositions and methods

Factor IXa inhibitors

Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction

Autotaxin inhibitors

Modulators of the p70S6 kinase for use in the treatment of brain disorders and triple-negative breast cancer

2-(pyridin-3-yl)-pyrimidine derivatives as RET inhibitors

Polymerizable compound and optical isomer

Substituted quinoxalines for inhibiting kinase activity

Compositions and methods for treating toxoplasmosis, cryptosporidiosis, and other apicomplexan protozoan related diseases

Therapeutic compounds and uses thereof

Cannabinoid receptor mediating compounds

Cannabinoid receptor mediating iminopyrazole compounds

GLP-1 receptor modulators

Autotaxin inhibitors

INHIBITORS OF HISTONE DEACETYLASE

QUINAZOLINE INHIBITORS OF ACTIVATING MUTANT FORMS OF EPIDERMAL GROWTH FACTOR RECEPTOR

SUBSTITUTED PYRIDAZINE CARBOXAMIDE COMPOUNDS

Substituted pyrazole compounds as RORgammaT inhibitors and uses thereof

Pyrazole compounds as nitrification inhibitors

Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activities

Substituted benzimidazolium compounds useful in the treatment of respiratory diseases

Heterocyclic compounds and use thereof

Quinazoline and quinoline compounds and uses thereof

Protein tyrosine kinase modulators and methods of use

Inhibitors of TrkA kinase

2-oxo-1,2-dihydrobenzo[cd]indole compound and use thereof

Tricyclic sulfones as RORγ modulators

Cot modulators and methods of use thereof

Bifunctional compounds and use for reducing uric acid levels

2-(pyrazin-2-ylcarbonylaminomethyl) benzimidazolium compounds as epithelial sodium channel inhibitors

TETRA- AND PENTASUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES

Tetrazolones as a carboxylic acid bioisosteres

(Thio, oxo, and seleno) semicarbazone derivatives and their use for treating cancer

N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as Wnt signaling modulators

Hydrazone derivatives for the treatment of cancer

Zinc complexes of hydrazones and (thio)semicarbazones and their use for the treatment of cancer

Polymerizable compound and optically anisotropic object

2,4-diamino-pyrimidine compounds and method for making and using the compounds

Methods for preparing fused bicyclic 2, 4-diaminopyrimidine derivatives

Kinase inhibitors for the treatment of disease

MONOCYCLIC HETEROARYL COMPOUNDS

Pyrazole P38 map kinase inhibitors

Purified cenicriviroc and purified intermediates for making cenicriviroc

COMPOUNDS, COMPOSITIONS, AND METHODS

Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase

PRO-SURVIVAL COMPOUNDS

Carbazole derivatives

Pyrimidine FGFR4 inhibitors

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

AMINE-SUBSTITUTED ARYL OR HETEROARYL COMPOUNDS

Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer

Ethyldiamine orexin receptor antagonists

C-met modulators and methods of use

Quinazoline compounds

SMALL MOLECULE MYRISTATE INHIBITORS OF BCR-ABL AND ABL AND METHODS OF USE

Heterocyclic derivatives as RORgamma modulators

Hedgehog antagonists having zinc binding moieties

Compounds and methods for kinase modulation, and indications therefor

Heterocyclic substituted 2-amino quinazoline derivatives for the treatment of viral infections

Inhibitors of lysine specific demethylase-1

Inhibitors of lysine specific demethylase-1

N,6-bis(aryl or heteroaryl)-1,3,5-triazine-2,4-diamine compounds as IDH2 mutants inhibitors for the treatment of cancer

Heteroaryl inhibitors of PDE4

ULK1 inhibitors and methods using same

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

SIK inhibitor for use in a method of treating an inflammatory and/or immune disorder

Aryl-cyanoguanidine compounds

Modulators of the eIF2alpha pathway

Targeted contrast agents comprising a hydrazide functional group

Inhibitors of human phosphatidylinositol 3-kinase delta

LIGANDS FOR ANTIBODY AND FC-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMOTOGRAPHY IV

Benzenesulfonamide compounds and their use as therapeutic agents

Dopamine D3 receptor antagonist compounds

Therapeutic compounds and uses thereof

Quinazoline derivatives substituted by aniline, preparation method and use thereof

NOVEL ANTI-INFLAMMATORY AGENTS

Optionally fused heterocyclyl-substituted derivatives of pyrimidine useful for the treatment of inflammatory, metabolic, oncologic and autoimmune diseases

CELL PROLIFERATION INHIBITORS AND CONJUGATES THEREOF

CARM1 inhibitors and uses thereof

Indane inhibitors of EED and methods of their use

Tetrahydroisoquinoline estrogen receptor modulators and uses thereof

Derivatives of 2-(1,2,4-triazol-3-ylsulfanyl)-N-1,3,4-thiadiazol-2-yl acetamide which are useful for the treatment of inter alia diabetes

Herbicidal compounds

Amidoethyl azole orexin receptor antagonists

Spiroacridine-triazine hybrids and applications for electroluminescent devices

Uracil derivatives as AXL and c-MET kinase inhibitors

HIV replication inhibiting pyrimidines

Triazabutadienes as cleavable cross-linkers

Pyrazole derivatives as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto